We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$45.5B
AUM Growth
+$3.35B
Cap. Flow
-$280M
Cap. Flow %
-0.61%
Top 10 Hldgs %
13.5%
Holding
2,214
New
196
Increased
865
Reduced
880
Closed
158

Top Buys

Rank Stock Value
1
VLTO icon
Veralto
VLTO
+$206M
2
PEP icon
PepsiCo
PEP
+$156M
3
JNJ icon
Johnson & Johnson
JNJ
+$155M
4
PAYX icon
Paychex
PAYX
+$146M
5
PLD icon
Prologis
PLD
+$141M

Top Sells

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$336M
2
DUK icon
Duke Energy
DUK
+$259M
3
KMB icon
Kimberly-Clark
KMB
+$213M
4
PM icon
Philip Morris
PM
+$206M
5
CRWD icon
CrowdStrike
CRWD
+$205M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Healthcare 17.4%
3 Financials 13.44%
4 Industrials 10.47%
5 Consumer Discretionary 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRM icon
2026
Perimeter Solutions
PRM
$5.66B
$40 ﹤0.01%
+3
New +$31
RELY icon
2027
Remitly
RELY
$4.9B
$40 ﹤0.01%
3
+2
+200% +$27
VSTO
2028
DELISTED
Vista Outdoor Inc.
VSTO
$39 ﹤0.01%
+1
New +$39
COGT icon
2029
Cogent Biosciences
COGT
$6.76B
$32 ﹤0.01%
3
+2
+200% +$19
GTN icon
2030
Gray Television
GTN
$437M
$32 ﹤0.01%
6
-47
-89% -$242
AUR icon
2031
Aurora
AUR
$11.7B
$30 ﹤0.01%
+5
New +$21
AUPH icon
2032
Aurinia Pharmaceuticals
AUPH
$1.95B
$29 ﹤0.01%
4
+3
+300% +$19
ACTG icon
2033
Acacia Research
ACTG
$437M
$28 ﹤0.01%
6
+5
+500% +$25
OCUL icon
2034
Ocular Therapeutix
OCUL
$1.83B
$26 ﹤0.01%
3
+2
+200% +$16
GRPN icon
2035
Groupon
GRPN
$1.03B
$20 ﹤0.01%
2
-414,700
-100% -$5.56M
LRMR icon
2036
Larimar Therapeutics
LRMR
$377M
$20 ﹤0.01%
3
+2
+200% +$16
INNV icon
2037
InnovAge Holding
INNV
$1.56B
$18 ﹤0.01%
3
+2
+200% +$12
SB icon
2038
Safe Bulkers
SB
$772M
$16 ﹤0.01%
3
-94
-97% -$483
MQ icon
2039
Marqeta
MQ
$1.93B
$15 ﹤0.01%
+1
New +$21
PRME icon
2040
Prime Medicine
PRME
$547M
$15 ﹤0.01%
+4
New +$19
SLRN
2041
DELISTED
ACELYRIN
SLRN
$15 ﹤0.01%
3
-5,383
-100% -$27.8K
AMC icon
2042
AMC Entertainment Holdings
AMC
$2.45B
$14 ﹤0.01%
+3
New +$15
SVRA icon
2043
Savara
SVRA
$1.08B
$13 ﹤0.01%
+3
New +$13
ABUS icon
2044
Arbutus Biopharma
ABUS
$847M
$12 ﹤0.01%
+3
New +$12
SANA icon
2045
Sana Biotechnology
SANA
$882M
$12 ﹤0.01%
+3
New +$16
ABSI icon
2046
Absci
ABSI
$1.17B
$11 ﹤0.01%
+3
New +$12
BANC icon
2047
Banc of California
BANC
$2.87B
$9 ﹤0.01%
1
LXRX icon
2048
Lexicon Pharmaceuticals
LXRX
$1.03B
$9 ﹤0.01%
6
+5
+500% +$9
EGY icon
2049
Vaalco Energy
EGY
$562M
$6 ﹤0.01%
1
GSAT icon
2050
Globalstar
GSAT
$10.1B
0

Similar funds

Federated Hermes's Q3 2024 Portfolio in Review

As of Q3 2024, Federated Hermes held 2,214 positions worth $45.5B, up 7.9% from $42.2B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q3 2024 filing shows 196 new, 865 increased, 880 reduced and 158 closed positions. Its largest new stake was SharkNinja: 915,637 shares worth $99.5M. The largest sale was Conagra Brands, an estimated $336M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q3 2024 buy was SharkNinja: 915,637 shares worth $99.5M.
  • Federated Hermes added most to Veralto in Q3 2024, an estimated $206M increase.
  • Federated Hermes's biggest Q3 2024 reduction was Conagra Brands, cutting an estimated $336M.
  • Federated Hermes fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $33.9M.
  • Federated Hermes's ten largest holdings make up 13% of its $45.5B portfolio in Q3 2024.
  • Federated Hermes opened 196 new positions and closed 158 in Q3 2024.
  • Federated Hermes's portfolio value rose 7.9% quarter-over-quarter to $45.5B.

Based on Federated Hermes's 13F filing for Q3 2024, filed 13 Nov 2024.